Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 278 participants.
Also called NCT02542631
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 278 participants
- Sponsor
- Registry
-
NCT02542631 -
2015-003761-28
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, France, Germany, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02542631. Randomized; no masking; primary purpose treatment. Start 2015-08-01 (actual); primary completion 2017-08-31 (actual). Results posted on 2018-11-07.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Device)
- Bolus Insulin Patch (Calibra Finesse)
- Intervention (Device)
- Insulin Pen (Novo-Nordisk FlexPen®)
- Lead sponsor
- Calibra Medical, Inc.
- Collaborator
- Medpace, Inc.
Record details
- Record id
cardio:ct-nct02542631- Content hash
c9697d38aedfa9cd17dd78300b85dcade920aa64d9d99080a579eae0308506e4